OncoSil Medical Limited (ASX:OSL) Secures $1.05 Million R&D Tax Incentive
OncoSil Medical secures a $1.05 million R&D tax incentive to support advancements in its pancreatic cancer treatment technology.
The Hub of Australian Finance News
OncoSil Medical secures a $1.05 million R&D tax incentive to support advancements in its pancreatic cancer treatment technology.
Focus Minerals Ltd confirms compliance with Listing Rules in response to an ASX price query.
Firstwave Cloud Technology Limited announces the lifting of its trading suspension, effective immediately.
Firstwave Cloud Technology (ASX:FCT) has announced a suspension of trading to maintain market integrity pending a sensitive announcement.
Papyrus Australia Ltd (ASX:PPY) revises November 2024 cash flow report, addressing expenses and outlining future funding strategy.
Aldoro Resources (ASX:ARN) completes a 5,160-meter trenching program and reports progress in its diamond drilling efforts.
Flexiroam Limited (ASX:FRX) announces a non-renounceable entitlement offer to raise up to $3.9 million for growth strategies.
iCandy Interactive Limited secures US$4 million seed funding for its ZKCandy joint venture, enhancing its Web3 gaming initiatives.
Challenger Gold Limited has requested a trading halt as it prepares to announce significant company developments.
Firstwave Cloud Technology Limited (ASX:FCT) has announced a temporary pause in trading of its securities pending further announcements.